Intervention for the Elderly With Malnutrition, Hidden Hunger and Low Skeletal Muscle Mass
NCT ID: NCT03648580
Last Updated: 2019-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2017-05-20
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Give the verbal nutrition education and supply Ensure Complete powder that will be the oral nutrition supplement, with the dose of 6 scoops (53.8 grams) twice daily.Duration: 12 weeks
Ensure Complete powder
Supply the Ensure Complete powder that will be the oral nutrition supplement, with the dose of 6 scoops (53.8 grams) twice daily.Duration: 12 weeks
verbal nutrition education
give the verbal nutrition education
Control group
just give the verbal nutrition education.
verbal nutrition education
give the verbal nutrition education
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ensure Complete powder
Supply the Ensure Complete powder that will be the oral nutrition supplement, with the dose of 6 scoops (53.8 grams) twice daily.Duration: 12 weeks
verbal nutrition education
give the verbal nutrition education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. the one with nutritional risk according to MNA-Short Form evaluation (score less than12);
3. the one who has low skeletal muscle mass (with bioelectrical impedance analysis report indicating that the skeletal muscle mass is less than 90% of the normal level) and/or the one who has at least 1 type of the micronutrient deficiency symptom (part A \< 40 or part A \< 85 in the hidden hungry evaluation questionnaire)
Exclusion Criteria
2. Liver failure in recent one year;
3. Renal insufficiency (serum creatinine is more than 2 times of normal value)
4. the one who is allergic to or not applicable to the component in oral dietary supplement;
5. the one with parkinsonism, epilepsy and other nervous system disorders;
6. malignant tumor patients with chemotherapy and chemotherapy;
7. irritable bowel disease and other chronic wasting diseases.
8. Taking multi-vitamin\&mineral supplements or protein or other oral nutritional supplements
65 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital with Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ting Zhao
Technologist-in-charge
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ting Zhao
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital with Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JYX201603
Identifier Type: -
Identifier Source: org_study_id